Amiodarone Therapy for Cardioversion to Sinus Rhythm
Introduction to Amiodarone Therapy
- The European Society of Cardiology recommends continuing amiodarone at a maintenance dose of 200 mg daily (or less) for long-term rhythm control after successful cardioversion, as this approach provides superior sinus rhythm maintenance compared to other antiarrhythmic agents while minimizing the risk of extracardiac toxicity 1, 2
Pre-Cardioversion Loading Strategy
- The optimal approach involves a loading period of 1-3 days before cardioversion for most antiarrhythmics, but amiodarone requires a few weeks of pre-treatment to achieve effective drug levels and improve cardioversion success 1, 2
- This loading strategy also enhances electrical cardioversion efficacy when needed 1, 2
Post-Cardioversion Maintenance Dosing
- The maintenance dose should be 200 mg daily or less to balance efficacy with safety, as low-dose amiodarone (200 mg daily or less) maintains effectiveness while reducing the incidence of serious side effects 3, 4
Efficacy Data
- Amiodarone demonstrates superior efficacy compared to alternatives, with 83% of patients remaining in sinus rhythm at 6 months with amiodarone versus 43% with quinidine 3, 4
- 69% of patients maintain sinus rhythm with amiodarone versus 39% with propafenone or sotalol over 16 months 5, 6
- In the SAFE-T trial, median time to AF recurrence was 487 days with amiodarone versus 74 days with sotalol 5, 6, 7
- Amiodarone approximately doubles sinus rhythm maintenance compared with no therapy 1, 2
Patient-Specific Considerations
- Amiodarone is the preferred first-line agent in patients with heart failure or significant structural heart disease due to low proarrhythmic risk 3, 4, 7
- In patients with ischemic heart disease, amiodarone (569 days) and sotalol (428 days) showed similar time to recurrence 5, 6, 7
Safety Monitoring
- 18% of patients discontinue amiodarone due to side effects after a mean of 468 days, compared to 11% with sotalol or propafenone 5, 6, 7
- Side effects tend to occur after prolonged treatment rather than in the first 6 months 3, 4
- Amiodarone provides the added benefit of effective rate control, frequently eliminating the need for additional rate-control medications 7, 8